Literature DB >> 23453874

Histopathology of the great vessels in patients with pulmonary arterial hypertension in association with congenital heart disease: large pulmonary arteries matter too.

Matina Prapa1, Karen P McCarthy, Konstantinos Dimopoulos, Mary N Sheppard, Dimitra Krexi, Lorna Swan, S John Wort, Michael A Gatzoulis, Siew Yen Ho.   

Abstract

BACKGROUND: Pulmonary arterial hypertension (PAH) is considered primarily a disease of the distal pulmonary arteries whereas little is known on the effect of long-standing pulmonary hypertension on the larger proximal pulmonary arteries. This study aims to investigate the structural changes in the great arteries of adults who developed PAH in association with congenital heart disease (CHD), with severe cases termed Eisenmenger syndrome.
METHODS: We performed macroscopic and light microscopy analyses on the great arteries of 10 formalin-fixed human hearts from patients with PAH/CHD and compared them to age-matched healthy controls. A detailed histology grading score was used to assess the severity of medial wall abnormalities.
RESULTS: Severe atherosclerotic lesions were found macroscopically in the elastic pulmonary arteries of 4 PAH/CHD specimens and organised thrombi in 3; none were present in the controls. Significant medial wall abnormalities were present in the pulmonary trunk (PT), including fibrosis (80%), and atypical elastic pattern (80%). Cyst-like formations were present in less than one third of patients and were severe in a single case leading to wall rupture. The cumulative PT histology grading score was significantly higher in PAH/CHD cases compared to controls (p<0.0001) and correlated positively with larger PT diameters (ρ=0.812, p<0.0001) and the degree of medial wall hypertrophy (ρ=0.749, p<0.0001).
CONCLUSIONS: Chronic PAH in association with CHD results in marked macroscopic and histological abnormalities in the large pulmonary arteries. These abnormalities are likely to affect haemodynamics and contribute to morbidity and mortality in this cohort.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Arteries; CHD; Congenital heart disease; ETC; HGS; LPA; PA; PAH; PT; PT/Ao MT; Pulmonary arterial hypertension; RPA; STJ; Structure; Tissue; congenital heart disease; elastic tissue configuration; histology grading score; left pulmonary artery; pulmonary arterial hypertension; pulmonary artery; pulmonary trunk; pulmonary trunk-to-aortic media thickness; right pulmonary artery; sinutubular junction

Mesh:

Year:  2013        PMID: 23453874     DOI: 10.1016/j.ijcard.2013.01.210

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

1.  Pulmonary artery smooth muscle cell hyperproliferation and metabolic shift triggered by pulmonary overcirculation.

Authors:  Jason Boehme; Xutong Sun; Kathryn V Tormos; Wenhui Gong; Manuela Kellner; Sanjeev A Datar; Rebecca Johnson Kameny; Jason X-J Yuan; Gary W Raff; Jeffrey R Fineman; Stephen M Black; Emin Maltepe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-02       Impact factor: 4.733

2.  Phase-contrast magnetic resonance imaging for analyzing hemodynamic parameters and wall shear stress of pulmonary arteries in patients with pulmonary arterial hypertension.

Authors:  Hung-Hsuan Wang; Wen-Yih Isaac Tseng; Hsi-Yu Yu; Meng-Chu Chang; Hsu-Hsia Peng
Journal:  MAGMA       Date:  2019-07-03       Impact factor: 2.310

3.  Proteasome inhibitor PS-341 attenuates flow-induced pulmonary arterial hypertension.

Authors:  Ya-Yun Wang; Yun Luan; Xue Zhang; Mei Lin; Zhao-Hua Zhang; Xiao-Bo Zhu; Yu Ma; Yi-Biao Wang
Journal:  Clin Exp Med       Date:  2013-06-16       Impact factor: 3.984

4.  Inverse modeling framework for characterizing patient-specific microstructural changes in the pulmonary arteries.

Authors:  Reza Pourmodheji; Zhenxiang Jiang; Christopher Tossas-Betancourt; C Alberto Figueroa; Seungik Baek; Lik-Chuan Lee
Journal:  J Mech Behav Biomed Mater       Date:  2021-03-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.